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Objectives . This study compared the relative risks and benefits
of coronary angioplasty and coronary artery bypass graft surgery
in patients >70 years old .
Background. Few objective, comparative data exist to guide the
clinician in the decision to use bypass surgery or angioplasity iii
elderly patients .
Methods. The study was a case-control, retrospective analysis
of 195 consecutive patients who underwent bypass surgery in 1987
and 1988 and were compared with a concurrent cohort of 195
coronary angioplasty-treated patients . The groups were matched
for left ventricular function, age and gender mix .
Results . The in-hospital morbidity and mortality rates were
significantly lower in the coronary angioplasty-treated patients.
Mean postprocedural hospital stay was 4.8 and 14.3 days for
angioplasty and surgical group patients, respectively (p < 0.001).
In-hospital death occurred in 2% of angioplasty-treated patients
Elderly patients today comprise the most rapidly expanding
segment of our population . Coronary artery disease becomes
progressively more prevalent with increasing age (1) . For
these reasons, cardiologists and cardiovascular surgeons are
increasingly faced with difficult decisions with regard to the
need for revascularization and the type of procedure to
select in these elderly patients . Although both coronary
angioplasty and coronary artery bypass graft surgery have
been commonly used in elderly patients for many years,
there is a paucity of objective, comparative data to help
guide clinicians and patients in this decision . Instead, the
clinician must rely on anecdotal experience, noncomparative
observational data and clinical intuition . Randomized trials
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compared with 9% of surgically treated patients (p = 0.007) .
Serious in-hospital stroke occurred in no patient in the angioplasty
group and in 5% of patients in the surgical group (p < 0 .0001) .
Q wave infarction occurred in I% of angioplasty-treated patients
and 6% of bypass-treated patients (p = 0 .01). The 5-year actuar-
ial survival rate was similar in the two groups : 63% in the
angioplasty group, 65% in the bypass group (p = NS) . However,
surgical group patients experienced less recurrent angina, re-
quired fewer repeat revascularization procedures and had fewer
Q wave infarctions during follow-up compared with angioplasty
group patients.
Conclusions. When performed in patients >70 years old,
angioplasty and coronary bypass surgery result in similar long-
term survival rates but otherwise distinctly different clinical
courses .
(I Am Cog Cardiol 1994,24.425-30)
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comparing bypass surgery and coronary angioplasty are in
progress, but these are being performed in selected groups
and may not be relevant to the more diverse population seen
in a typical clinical practice, particularly the elderly cohort .
The nonrandomized, observational studies that have
compared coronary angioplasty and bypass surgery have
been flawed by important baseline differences between the
two groups (2-5) . In most medical centers today, a selection
bias exists whereby patients undergoing coronary artery
bypass graft surgery often have poorer left ventricular sys-
tolic function compared with angioplasty-treated patients
(2-6). Left ventricular function has a profound effect on both
short- and long-term outcome in patients with coronary
artery disease (6-9)
. Thus, comparative studies of bypass
surgery- and angioplasty-treated patients with baseline dif-
ferences in left ventricular function are difficult to interpret .
The purpose of the current study was to compare the
relative risks and benefits of coronary angioplasty and
bypass surgery in patients >70 years old . The groups were
matched for left ventricular systolic function as measured by
ejection fraction and were similar with respect to most other
major angiographic and demographic variables
.
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Methods
Patitnts.
This study was a retrospective analysis of 390
elderly patients who underwent either elective coronary
artery bypass graft surgery or elective coronary angioplasty
between January 1, 1987 and December 31, 1988 . The
surgical group represented a consecutive series of 195 pa-
tients >70 years old who underwent elective coronary artery
bypass graft surgery at the Mid-America Heart Institute at
St. Luke's Hospital in Kansas City, Missouri. The angio-
plasty group included concurrent cohort of 195 similar
patients randomly selected from the same time frame and
matched for I) left ventricular systolic function, as measured
by ejection fraction on the preprocedural left ventriculo-
gram, 2) age, and 3) gender. Patients were excluded if
significant left main coronary artery disease was noted
(L lumen diameter stenosis) . Demographic, clinical and
angiogrophic data were compared using the Student t test,
chi-square test or Fisher exact test when appropriate . All
reported p values were two-tailed . Long-term survival was
compared using the Kaplan-Meyer method . Long-term sur-
vival curves included procedural and in-hospital mortality
rates, Late results were compared using univariate actuarial
(life table) and multiple regression (Cox) survival analyses .
. Transmural myocardial infarction was de-
fined as the appearance of new Q waves supported by
creatine kinase, MB fraction enzyme elevation . In-hospital
death was defined as all-cause mortality during the index
hospital stay . Baseline left ventricular ejection fraction was
documented by left ventriculography at cardiac catheteriza-
tion or echocardiography . or both . Incomplete revascular-
ization was defined as any lesion z5O% lumen diameter
stenosis in a major epicardial coronary artery or branch
(z1.5 mm in diameter) that was either not attempted or not
successfully dilated' during the angioplasty procedure or not
bypassed during the surgical procedure . The diagnosis of
cerebrovascular accident required all three of the following:
1) neurologic findings on history and physical examination
consistent with a diagnosis of stroke ; 2) computed tomo-
is or magnetic resonance image documentation, or
both; and 3) a persistent neurologic deficit at the time of
dismissal .
C
ure. Percutaneous translu-
minal coronary angioplasty was performed using standard
techniques described elsewhere (10). Complete revascular-
ization through dilation of all significant stenoses during a
singe procedure was our strategy whenever possible . Pa-
tients were pretreated with aspirin (325 mg) ; dipyridamole
(75 mg three times daily) and a calcium channel blocking
agent were also often used . On arrival in the catheterization
laboratory, patients received lidocaine, sublingual nitrates
and verapamil. A dextran infusion was variably used de-
pending on operator preference . At the beginning of the
procedure an intravenous bolus injection of 10,000 U of
heparin was given, followed by a bolus of -5,000 U/h of
Table 1. Baseline Data
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CABG = coronary artery bypass graft surgery ; LVEF - left ventricular
ejection fraction ; PTCA = percutaneous tratesluntinal coronary angioplasty .
elapsed time during the procedure. Aspirin, 325 Ing daily,
was continued indefinitely after the procedure .
Co artery by graft surgery. Patients under-
went coronary artery bypass graft surgery us®ng cold cardio-
plegia. The left internal mammary graft was used to bypass
the left anterior descending coronary artery whenever pos-
sible. Reversed saphenous vein graft segments were gener-
ally used to bypass diseased vessels in the left circumflex or
right coronary systems. Patients were given aspirin (325 mg
daily) and dipyridamole (75 mg three times daily) at dis-
charge from hospital .
line characteristics . The baseline demographics and
angiographic descriptors of the two groups are presented in
Table 1 . Angioplasty and bypass group patients were iden-
tical with respect to left ventricular systolic function. Mean
left ventricular ejection fraction was 46.8 ± 15% and 46.7
15% in angioplasty and bypass group patients, respectively .
The groups were also indistinguishable with respect to mean
age (75 years) and gender mix (two of three patients in both
groups were male) . Multivessel disease was the dominant
pathoanatomy in both groups but was seen somewhat more
frequently in those patients who underwent bypass surgery .
Coronary artery disease involving two or more of the major
epicardial coronary systems was seen in 97% of surgical
group patients and in 84% of angioplasty group patients
(p < 0 .001). A mean of 3 .7 distal anastomoses per patient
were performed in surgically treated patients . A mean of 2 .1
vessels were dilated in angioplasty-treated patients . Previous
revascularization procedures were noted more frequently in
angioplasty-treated patients . Unstable angina was the indica-
tion for revascularization in 53% of angioplasty and 63% of
surgical group patients.
Follow-up . Prospective long-term follow-up data were
obtained from mailed questionnaires, telephone interviews
and follow-up patient visits. This information was stored in a
computer data base and updated on a systematic, periodic
basis. Four patients (1%) were lost to follow-up . The mean
(± SD) duration of follow-up for the 390 patients was 38 ± 19
months.
PTCA
In _ 195)
CABG
(n = 195) p Value
Mean age (yr) 75 75 NS
Male 1330%) 131(67%) NS
Female 8302%) 6403%) NS
Previous CABG 49(25%) 17 (9%) < 0 . 1
Previous PTCA 64(33%) 24(12%) < 0.0001
Diseased vessels
1 31 (16%) 6(3%)
2 6905%) 45 (2317b) < 0 .0001
3 95 (49%) 144(77%)
Mean LVEF 47% 47% NS
Unstable angina 103(53%) 123(63%) 0.05
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Table 2. In-Hospital Complications
CVA = cerebrovascular accident ; MI = myocardial infarction; other
abbreviations as in Table 1 .
Results
In-hospital complications occurred more frequently in
bypass group patients (Table 2). Death during the initial
hospital stay occurred in four patients (2%) in the angio-
plasty group and 17 patients (9%) in the bypass group (p =
0.007). Stroke and Q wave myocardial infarction also oc-
curred significantly more often in bypass group patients
. The
mean duration of hospital stay was 4 .8 ± 5 .6 days in
angioplasty group patients and 14.3 ± 11 days in bypass
group patients (p < 0
.001). The average daily hospital charge
was $2,940/day for angioplasty group patients and $2,236/
day for surgical group patients . The total hospital charge for
the index revascularization hospital stay was $11,652
$7,574 for angioplasty and $31,334 ± $24,520 for surgery
.
Long-term actuarial survival rate curves, including in-
hospital mortality, were not significantly different (Fig . 1) .
Although survival rates at I week favored angioplasty, this
advantage was entirely lost by I year, and the curves
appeared to parallel each other over the ensuing 4 years of
follow-up. Complete revascularization was achieved in 194
bypass group patients (99%) and 74 angioplasty group pa-
tients (37%) (p < 0 .0001) . The survival rate of angioplasty
group patients with complete revascularization was identical
to that of the surgical group ; however, the long-term survival
rate of angioplasty group patients with incomplete revascu-
larization was significantly lower (Fig . 2). Event-free sur-
Figure 1. Acturial survival rate in coronary angioplasty (squares)
and coronary artery bypass graft surgery (circles) groups . The 5-year
survival rate was 63% in angioplasty group patients and 65% in
surgery group patients (p = NS) . At hospital discharge (1 week) a
survival rate advantage was noted in the coronary angioplasty
group
. The curves crossed over by I year and remained essentially
identical thereafter .
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Figure 2 . Survival rate as a function of completeness of revascular-
iLation . The nearly all surgical group patients (circles) had complete
revascularization (99%) . The survival rate of angioplasty group
patients with complete revascularization (squares) was equivalent to
that of the surgical group . The survival rate of angioplasty group
patients with incomplete revascularization (diamands) was signifi-
cantly lower than patients with complete revascularization .
viva] (freedom from death or Q wave infarction) was signif-
icantly better in the surgically treated patients (Fig . 3). At
the end of 5 years, 59% of bypass group patients and 40% of
angioplasty group patients were free from recurrent cardiac
events. Freedom from repeat revascularization was also
different in the two groups (Fig . 4) . Of the angioplasty group
patients >50% required repeat revascularization during the
5-year follow-up . In addition, surgical group patients ex-
perienced superior relief from recurrent angina during
follow-up (Fig. 5) . Late cardiac events doting follow-up for
the two groups are displayed in Table 3 .
Multivariate correlates of mortality rate during long-term
follow-up as determined by the Cox proportional hazards
survival model were left ventricular ejection fraction s40%,
unstable angina at presentation and incomplete revascular-
ization. Mode of revascularization (angioplasty or bypass
surgery) was not an independent predictor of long-term
survival rate by multivariate analysis
.
Figure 3 . Event-free survival (freedom from death or Q wave
myocardial infarction) was significantly better in bypass group
patients (circles) than in angioplasty group patients (squares)
.
0
0 1 2 3
4
Years
PICA CABG p Value
In-hospital death 4 (2%) 17 (97r) 0 .007
CVA 0 10(5%) < 0 .0001
Q wave MI
2 (1%) 12(6%) 0 .014
Urgent CADG 2 (1%) 0 < 0 .0001
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FIgure 4 . Freedom from repeat revascularization
. Repeat proce-
dures were rec 'red significantly more often in angioplasty group
patients (squarer) than in bypass group patients (circles)
.
Discussion
The most significant finding in this matched study of
patients >70 years old was the nearly identical long-term
survival rate in both angioplasty and bypass surgery groups .
Although bypass surgery appeared to result in more com-
plete and lasting coronary revascularization, this did not
translate into an improved survival rate . The mean age of the
patients in both groups was 75 years
. Because of associated
comorbidity and intrinsic limits on life expectancy . it
may be
difficult to demonstrate a long-term survival advantage for
any intervention in a population of this age. This is especially
true if the intervention entails a significant procedure-related
mortality risk (as is the case with bypass surgery) . These
comparative survival rate statistics cannot be extrapolated
to elderly patients with significant left main coronary disease
because they were excluded from the current study .
In- events . In this elderly cohort, procedural and
in-hospital morbidity and mortality rates were significantly
5. Angina class at follow-up . Surgical group patients (said
bars) were less symptomatic than angioplasty group patients (open
bars) at a mean follow-up of 38 months (p = O .02).
Table 3 . Cardiac Events During Follow-Up
Abbreviations as in Tables I and 2 .
higher in patients who underwent bypass surgery compared
with angioplasty-treated patients . Nearly one in 10 of surgi-
cally treated patients did not survive the initial hospital stay ;
an additional 5% had significant stroke . Several previous
noncomparative studies evaluating bypass surgery in the
elderly have documented increased risks with advancing
age. This increased risk becomes apparent at -60 to 65 years
of age and increases rapidly after 70 years of age (I1-16) .
The procedural risks of coronary angioplasty were also
increased in elderly patients compared with younger co-
horts. However, in elderly patients the absolute mortality
rates with angioplasty have been significantly lower than
those reported with coronary bypass surgery (17-22) . The
increased procedure-related morbidity with bypass surgery
in the elderly was demonstrated by the different mean
hospital stays from procedure until discharge for the two
groups
: > 14 days for surgery group patients compared with
4.8 days for angioplasty group patients .
Events during follow-up. Recurrent angina occurred more
often in patients who underwent coronary angioplasty, and
>50% of these patients had a repeat revascularization proce-
dure o`er the 5-year follow-up period . In contrast . patients
who underwent bypass surgery rarely required a second
procedure
. Q wave myocardial infarction during follow-up
was also increased in angioplasty group patients . The more
complete and lasting revascularization probably accounted
for the "crossover effect" noted in the two groups with respect
to long-term follow-up mortality . Although the initial proce-
dural mortality was significantly lower in angioplasty group
patients compared with the bypass group patients (2% vs
.
9%, respectively), by I year survival was equivalent in the
two groups and remained so for the 5-year follow-up period
(Fig
. 1) . This crossover of the survival curves during the first
year has been seen in another comparative study at our
institution (6) . This phenomenon may in part be a manifes-
tation of the frequent occurrence of incomplete revascular-
ization and restenosis with coronary angioplasty (problems
that are more common in patients with multivessel coronary
artery disease) (23) . The subgroup of angioplasty-treated
patients with incomplete revascularization had a higher
mortality rate during follow-up than patients with complete
revascularization by angioplasty or surgery . In a previous
study, we reported similar effects of complete revasculariza-
tion in patients with multivessel disease and left ventricular
dysfunction (left ventricular ejection fraction s40%) (6) .
PICA CABG P Value
Death 62 (32%) 59 (30%) NS
Q wave Ml
17 (9170 3 (2%c) ` 0 .01
Repeat revascularization 75(38%) 13 (7%)
< 0.000)
CABG 3307%) 1](67o) < 0.00!1
PTCA 62(32%) 13(7%) < 0.001
JACC Vol . 24, No . 2
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Stroke. Significant stroke during the initial hospital stay
occurred in 5% of surgery group patients and in none of the
angioplasty group patients . The incidence of perioperative
stroke in the current series is higher than the typically
reported stroke rates of -1% to 2% in younger cohorts
(24,25). Advanced age is a powerful risk factor for stroke in
patients undergoing bypass surgery, with reported stroke rates
of 2.6% to 8 .5% in elderly patients (3,16-18,26-28) . When
patients contemplate the decision to undergo a procedure,
debilitating stroke is usually a major consideration . The com-
parative stroke risks in this study strongly favored angioplasty
and should be factored into decisions about revascularization
procedures in elderly patients
. These data were collected in
1987 and 1988, and it is possible that the occurrence of stroke
with bypass surgery will decrease as preoperative screening,
cardiopulmonary bypass techniques and prophylactic mea-
sures continue to evolve .
Cost. The total in-hospital charge for the index hospital
stay was nearly $20,000lpatient more for bypass group than
angioplasty group patients . Although comparative long-term
costs were not available for these two groups, the early cost
advantage for angioplasty group patients was undoubtedly
eroded to some degree by the increased need for repeat
revascularization procedures in this group . Prospective eco-
nomic data have been collected at this institution from a
matched cohort of 200 patients with a mean age of 70 years
who presented with multivebbel coronary artery disease and
underwent either bypass surgery or coronary angioplasty in
1986. The initial hospital stay charges were nearly identical
to those noted for the 1987 and 1988 cohort of the current
study, showing an impressive cost advantage for angioplasty
group patients
. However, over the mean follow-up period of
5 years, -50% of the initial cost savings realized by the
angioplasty strategy had been dissipated .
Study limitations . This was a nonrandomized, retrospec-
tive study with all the inherent limitations of such a trial .
Some selection bias was unquestionably present in the two
groups
. We attempted to neutralize the most powerful vari-
able with respect to short- and long-term survival (left
ventricular systolic function) by matching the two groups for
left ventricular ejection fraction . The two groups were
similar in most respects, although surgical group patients
had a higher incidence of multivessel coronary artery disease
(97176 vs . 84%) and unstable angina at baseline (63% vs
.
53%). Specifically, the incidence of three-vessel disease was
77% in surgical versus 49% in angioplasty group patients
.
However, angioplasty group patients had undergone previ-
ous bypass surgery or percutaneous transluminal coronary
angioplasty, or both, more often .
The sample size of the two groups were relatively small (a
total of 390 patients were evaluated and followed up)
. These
findings will need to be confirmed by larger, multicenter
prospective and retrospective studies
. Two randomized
trials (Randomized Intervention Treatment of Angina
[RITA] [29] and German Angioplasty Bypass Investigation
[GABI] [30)) comparing bypass surgery and coronary angio-
plasty have recently reported preliminary results . These
studies, performed in a younger cohort, documented an
outcome similar to the current study . Angioplasty-treated
patients were noted to have a lower rate of early mortality
and morbidity, with an increased need for repeat revascu-
larization during follow-up
; but long-term survival rates
were similar to surgically treated patients . The Bypass
Angioplasty Revascularization Investigation (BARI) and the
Emory Angioplasty Surgery Trial (EAST) are also random-
ized trials evaluating this question, but results are not yet
available (31) .
Conclusions . The elderly patients in our study who un-
derwent revascularization had a similar survival rate but
otherwise a distinctly different clinical outcome, depending
on whether they were treated with bypass surgery or coro
.
nary angioplasty . Some elderly patients who are otherwise
free of comorbidity may choose to undergo coronary bypass
surgery despite the significant short-term risks, with the
hope that this will probably be a more "curative" procedure
without need for further intervention . However, the elderly
patient in need of coronary revascularization who wishes to
minimize procedural risks, including stroke, myocardial infarc-
tion and death, may choose coronary angioplasty, with the
undustanding that further procedures may be required .
These data do not provide a clear mandate with respect to
the superiority of either coronary bypass surgery or coro-
nary angioplasty in the elderly patient . Rather, they help to
characterize more definitively expected clinical outcomes
depending on the mode of revascularization chosen . This
information should facilitate more intelligent and informed
decision making by the involved clinical physicians and the
patients and their familic_,
.
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